Creatinine Assay Kit is kit which provides an accurate, convenient measure of creatinineconcentration in biological fluids such as serum, urine or CSF.
Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders are the key drivers of the global creatinine assay kits market.

Market Analysis and Insights: Global Creatinine Assay Kits Market
The global Creatinine Assay Kits market was valued at US$ 184.3 in 2020 and will reach US$ 220.1 million by the end of 2027, growing at a CAGR of 3.0% during 2022-2027.

Global Creatinine Assay Kits Scope and Market Size
The global Creatinine Assay Kits market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Creatinine Assay Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Jaffe's Kinetic Test
Creatinine-PAP
ELISA

Segment by Application
Blood
Serum
Urine
Saliva
Tissue Homogenate
Others

The Creatinine Assay Kits market is analysed and market size information is provided by regions (countries). Segment by Application, the Creatinine Assay Kits market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Thermo Fisher Scientific (US)
Merck (Germany)
Abbott Laboratories (US)
Abcam (UK)
Quidel (US)
Enzo Life Sciences (US)
Cayman Chemical (US)
Crystal Chem (US)
Cell Biolabs (US)
Genway Biotech (US)
BioAssay Systems (US)
Wako Pure Chemical Industries (Japan)
Tulip Diagnostics (India)
BioVision (US)
Arbor Assays (US)